Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biomea Fusion, Inc. - Common Stock
(NQ:
BMEA
)
1.800
-0.010 (-0.55%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biomea Fusion, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
These stocks are moving in today's after hours session
June 24, 2025
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via
Chartmill
Biomea Fusion Presents New Preclinical and Clinical Data on Icovamenib at the 85th Scientific Sessions of the American Diabetes Association (ADA)
June 23, 2025
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Which stocks are experiencing notable movement on Wednesday?
June 18, 2025
Curious to know what's happening on the US markets one hour before the close of the markets on Wednesday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
Crude Oil Moves Higher; US Weekly Jobless Claims Decline
June 18, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 18, 2025
Via
Benzinga
Here are the top movers in Wednesday's session.
June 18, 2025
Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
Which stocks are gapping on Wednesday?
June 18, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday.
Via
Chartmill
Biomea Fusion Reports Preclinical Data for BMF-650, a Next-Generation Oral GLP-1 Receptor Agonist Candidate, Demonstrating Robust Weight Loss and Appetite Suppression in Obese Non-Human Primates
June 18, 2025
From
Biomea Fusion, Inc.
Via
GlobeNewswire
US Stocks Likely To Open Higher Despite Trump's 'Unconditional Surrender' Call: All Eyes On Powell As Experts Predict Inflation Will Limit Fed's Rate Cut Capacity
June 18, 2025
U.S. futures were higher on Wednesday as oil futures tumbled after Donald Trump called for an "Unconditional Surrender" by Iran late Tuesday.
Via
Benzinga
Topics
Economy
Government
Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket
June 18, 2025
Via
Benzinga
Biomea Fusion Announces Pricing of Public Offering of Securities
June 17, 2025
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion Slides After-Hours Following Stock-And-Warrant Offering; Retail Traders See Rebound Ahead
June 17, 2025
The offering follows early clinical data from Biomea’s BMF-500 leukemia program, which showed encouraging responses in heavily pretreated patients.
Via
Stocktwits
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 17, 2025
Via
Benzinga
Top movers in Tuesday's after hours session
June 17, 2025
Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics.
Via
Chartmill
Biomea Fusion Announces Proposed Public Offering of Securities
June 17, 2025
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion Presents Updated Preliminary Clinical Data for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia at EHA 2025
June 13, 2025
New clinical results show sustained CRi, deep bone marrow responses, and encouraging survival in FLT3-mutant AML patients, including those previously treated with gilteritinib
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Which stocks have an unusual volume on Wednesday?
June 04, 2025
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the stocks with an unusual volume in today's session.
Via
Chartmill
Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities
June 04, 2025
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:OTLK),(NASDAQ:EYEN),(NYSE:BLCO),(NASDAQ:BMEA) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Wondering what's happening in today's after-hours session?
June 03, 2025
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities
June 04, 2025
From
FN Media Group LLC
Via
GlobeNewswire
What's going on in today's session
June 03, 2025
Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 03, 2025
Via
Benzinga
Which stocks are moving on Tuesday?
June 03, 2025
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via
Chartmill
Biomea Fusion’s BMF-500 Selected for Poster Presentation at EHA 2025 Highlighting Phase I Data in Relapsed/Refractory Acute Leukemia
May 14, 2025
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion's Stock Plummets After Price Target Cut — Bearish Retail Traders Speculate Next Moves
May 07, 2025
Biomea Fusion is realigning its focus on diabetes and obesity programs, cutting 35% of its workforce and consolidating operations to reduce costs.
Via
Stocktwits
Biomea Fusion Reports First Quarter 2025 Financial Results and Corporate Highlights
May 05, 2025
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 01, 2025
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
March 31, 2025
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion Announces Leadership Transition
March 25, 2025
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last Dose
March 24, 2025
From
Biomea Fusion, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.